Literature DB >> 10517448

Recurrent cervical carcinoma: typical and atypical manifestations.

A S Fulcher1, S G O'Sullivan, E M Segreti, B D Kavanagh.   

Abstract

After treatment of cervical carcinoma, recurrent disease may be observed in multiple sites at imaging. Both typical and atypical manifestations of recurrent disease occur. Typical manifestations of recurrent cervical carcinoma involve the pelvis and lymph nodes. Pelvic recurrences may be observed as masses involving the cervix and uterus, vagina or vaginal cuff, parametria, bladder, ureters, rectum, or ovaries and may result in fistula formation or hydronephrosis. Nodal recurrence may be identified as enlarged pelvic and retroperitoneal nodes. Atypical manifestations of recurrent cervical carcinoma are being recognized with greater frequency due to the use of intensive pelvic radiation therapy, the evolution of improved imaging techniques, and the more frequent use of imaging as a means of surveillance. These atypical manifestations may involve the solid organs of the abdomen (focal masses) as well as the peritoneum, mesentery, and omentum (implants); gastrointestinal tract (obstruction, fistula formation, ischemia); chest (metastases to the lung parenchyma, pleura, and pericardium); bones (destructive lesions); and other sites. Familiarity with the imaging features of recurrent cervical carcinoma in these anatomic locations will facilitate prompt, accurate diagnosis and treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10517448     DOI: 10.1148/radiographics.19.suppl_1.g99oc19s103

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  17 in total

1.  Cervical cancer: MR imaging findings before, during, and after radiation therapy.

Authors:  Gulgun Engin
Journal:  Eur Radiol       Date:  2005-06-14       Impact factor: 5.315

2.  Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma.

Authors:  Alexander Lin; Sirui Ma; Farrokh Dehdashti; Stephanie Markovina; Julie Schwarz; Barry Siegel; Matthew Powell; Perry Grigsby
Journal:  Int J Gynecol Cancer       Date:  2019-02-09       Impact factor: 3.437

3.  Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences.

Authors:  Rita Lucas; João Lopes Dias; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Sep-Oct       Impact factor: 2.630

Review 4.  Recurrent uterine cervical carcinoma: spectrum of imaging findings.

Authors:  J I Choi; S H Kim; C K Seong; J S Sim; H J Lee; K H Do
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

5.  Bone involvement by adenocarcinoma of the uterine cervix: a rare entity.

Authors:  Vincenzina Crisci; Pier Paolo Mainenti; Fabio Corvino; Rossella Lauria; Simone Maurea
Journal:  Pol J Radiol       Date:  2015-02-14

Review 6.  Advances in diagnosis and treatment of metastatic cervical cancer.

Authors:  Haoran Li; Xiaohua Wu; Xi Cheng
Journal:  J Gynecol Oncol       Date:  2016-07       Impact factor: 4.401

7.  Femur metastasis in carcinoma of the uterine cervix: a rare entity.

Authors:  Giacomo Corrado; Salvatore Santaguida; Gianfranco Zannoni; Giovanni Scambia; Gabriella Ferrandina
Journal:  Arch Gynecol Obstet       Date:  2009-12-02       Impact factor: 2.344

8.  Multi-modality organ-based approach to expected imaging findings, complications and recurrent tumour in the genitourinary tract after radiotherapy.

Authors:  Nicola Schieda; Shawn Christopher Malone; Omran Al Dandan; Parvati Ramchandani; Evan S Siegelman
Journal:  Insights Imaging       Date:  2013-11-26

9.  Recurrent cervical cancer isolated to the sigmoid colon: A case report.

Authors:  Joyce N Barlin; Josephine S Kim; Richard R Barakat
Journal:  Gynecol Oncol Case Rep       Date:  2013-07-22

10.  Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?

Authors:  Tao Ji; Ramez Eskander; Yifei Wang; Kunkun Sun; Bang H Hoang; Wei Guo
Journal:  World J Surg Oncol       Date:  2014-08-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.